ARCHIVES

Blinatumomab Demonstrates High Response Rate in ALL

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: Lasker Foundation Will Not Make 1990 Awards; Michigan Cancer Elects Fischer Vice Chairman

March 2, 1990

Graalman Objects To Criticism On Contract Competition

April 22, 1977

NKTR-102 Shows 29 Percent Response in Phase II Study

September 30, 2011

Funding Opportunities

September 27, 2002

NIH Programs: Mouse Is next In Line For DNA Sequencing

October 29, 1999

In Brief: Edwards Takes A Parting Shot At Cancer Program; “Forward Plan” Calls For Emphasis On Prevention

January 17, 1975